APA (7th ed.) Citation

AS, B., S, A., JA, C., CM, R., & EA, M. (2024). Survival Benefit from Multimodal Treatment for Patients with Atypical Teratoid Rhabdoid Tumor in a Surveillance, Epidemiology, and End Results Database Analysis. Oncology, 102(2), 183. https://doi.org/10.1159/000533508

Chicago Style (17th ed.) Citation

AS, Bhutada, Adhikari S, Cuoco JA, Rogers CM, and Marvin EA. "Survival Benefit from Multimodal Treatment for Patients with Atypical Teratoid Rhabdoid Tumor in a Surveillance, Epidemiology, and End Results Database Analysis." Oncology 102, no. 2 (2024): 183. https://doi.org/10.1159/000533508.

MLA (9th ed.) Citation

AS, Bhutada, et al. "Survival Benefit from Multimodal Treatment for Patients with Atypical Teratoid Rhabdoid Tumor in a Surveillance, Epidemiology, and End Results Database Analysis." Oncology, vol. 102, no. 2, 2024, p. 183, https://doi.org/10.1159/000533508.